Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Increased afterload results in 'pathological' cardiac hypertrophy, the most important risk factor for the development of heart failure. Current in vitro models fall short in deciphering the mechanisms of hypertrophy induced by afterload enhancement. The aim of this study was to develop an experimental model that allows investigating the impact of afterload enhancement (AE) on work-performing heart muscles in vitro. Fibrin-based engineered heart tissue (EHT) was cast between two hollow elastic silicone posts in a 24-well cell culture format. After 2 weeks, the posts were reinforced with metal braces, which markedly increased afterload of the spontaneously beating EHTs. Serum-free, triiodothyronine-, and hydrocortisone-supplemented medium conditions were established to prevent undefined serum effects. Control EHTs were handled identically without reinforcement. Endothelin-1 (ET-1)- or phenylephrine (PE)-stimulated EHTs served as positive control for hypertrophy. Cardiomyocytes in EHTs enlarged by 28.4 % under AE and to a similar extent by ET-1- or PE-stimulation (40.6 or 23.6 %), as determined by dystrophin staining. Cardiomyocyte hypertrophy was accompanied by activation of the fetal gene program, increased glucose consumption, and increased mRNA levels and extracellular deposition of collagen-1. Importantly, afterload-enhanced EHTs exhibited reduced contractile force and impaired diastolic relaxation directly after release of the metal braces. These deleterious effects of afterload enhancement were preventable by endothelin-A, but not endothelin-B receptor blockade. Sustained afterload enhancement of EHTs alone is sufficient to induce pathological cardiac remodeling with reduced contractile function and increased glucose consumption. The model will be useful to investigate novel therapeutic approaches in a simple and fast manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EHTs provide the opportunity to measure contractile function, Frank-Starling mechanism, and investigate the effects of mechanical and electrical stimulation [233,234].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [233]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797
RetractedThe Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417 · cited 1×
“Alterations in cardiomyocyte energetics in pathological cardiac hypertrophy with a shift from fatty acids (normally 60–90 %) to glucose as the primary myocardial energy substrate are described [3, 8, 27, 36].”
BackgroundThe progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155 · cited 2×
“Left ventricular hypertrophy is the most important antecedent risk factor for the development of heart failure [21].”
BackgroundRegulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866 · cited 1×
“Second, it shows that afterload enhancement as such induces pathological hypertrophy, independent of other well known factors such as systemic neurohumoral activation [13] and the mismatch”
BackgroundBleumink, G. S., KNETSCH, A., Sturkenboom, M., Straus, S. E., Albert Hofman, D., Deckers, J. W., Witteman, J. C. M., & Stricker, B. H. C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.038 · Cited by 1,173 · cited 1×
“Its prevalence in the general population is 1–2 %, but reaches more than 10 % in octogenarians [4].”
BackgroundHill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065 · cited 2×
“Besides neurohumoral activation chronically increased hemodynamic load is the main trigger of cardiac hypertrophy in patients [14].”
BackgroundShiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 939 · cited 1×
“between the growth of blood vessels and myocytes [33].”
BackgroundTissue Engineering of a Differentiated Cardiac Muscle Construct
Zimmermann, W.-H., Schneiderbanger, K., Schubert, P., Didié, M., Münzel, F., Heubach, J. F., Kostin, S., Neuhuber, W. L., & Eschenhagen, T. (2002) · Circulation Research · doi:10.1161/hh0202.103644 · Cited by 917 · cited 1×
“On the one hand, fibrin as ECM for tissue engineering allows unambiguous detection of freshly synthesized collagen-1 whereas collagen-1 as used by us previously [43] does not.”
BackgroundSelf-citationECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902 · cited 2×
“The present findings indeed show that EHTs allow studying processes as complex as cardiac fibrosis, known to involve activated fibroblasts (myofibroblasts), endothelial cells, cardiomyocytes and monocytes [2, 24].”
BackgroundTHE CELLULAR AND MOLECULAR RESPONSE OF CARDIAC MYOCYTES TO MECHANICAL STRESS
Sadoshima, J., & Izumo, S. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.551 · Cited by 864 · cited 1×
“able by endothelin blockers, nicely supporting either the early concept of autocrine or paracrine release of ET-1 and Ang II [30, 42], or a direct mechanically induced activation”
Background
Cited by
Organ-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Cardiac Tissue Engineering: State of the Art
Hirt, M. N., Hansen, A., & Eschenhagen, T. (2014) · Circulation Research · doi:10.1161/circresaha.114.300522 · Cited by 425
Self-citationHuman Engineered Heart Tissue: Analysis of Contractile Force
Mannhardt, I., Breckwoldt, K., Letuffe-Brenière, D., Schaaf, S., Schulz, H., Neuber, C., Benzin, A., Werner, T., Eder, A., Schulze, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.011 · Cited by 398
“by inserting metal braces induced a phenotype of pathological cardiac hypertrophy in rat EHTs (Hirt et al., 2012), indicating that culture under isometric conditions (stiff posts or 2D cultures on plastic surfaces) may in fact induce a pathological phenotype.”
BackgroundSelf-citationHirt, M. N., Boeddinghaus, J., Mitchell, A., Schaaf, S., Börnchen, C., Müller, C., Schulz, H., Hubner, N., Stenzig, J., Stoehr, A., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.009 · Cited by 352
“Part of this difference is due to amuch lower volume fraction occupied by cardiomyocytes (compared to cell-free matrix) [11].”
InfluentialSelf-citationElectrical and mechanical stimulation of cardiac cells and tissue constructs
Stoppel, W. L., Kaplan, D. L., & Black, L. D. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.009 · Cited by 289
“To create in vitro models of disease, stiff rods replaced the soft PDMS pillars to mimic increased afterload [291].”
Method
Metadata
- Authors
- Hirt, M. N., Sörensen, N. A., Bartholdt, L. M., Boeddinghaus, J., Schaaf, S., Eder, A., Vollert, I., Stöhr, A., Schulze, T., Witten, A., Stoll, M., Hansen, A., & Eschenhagen, T.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- ORCID
- Venue
- Basic Research in Cardiology
- Published
- 2012-10-26
- Volume
- 107
- Issue
- 6
- Pages
- 307-307
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- PMC
- PMC3505530
- OpenAlex
- W2024763420
- Cited by
- 154
- References
- 45
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 14 · 2021: 19 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 10 · 2016: 13 · 2015: 11 · 2014: 11 · 2013: 7
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Basic Research in Cardiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission
- Deutsche Forschungsgemeinschaft (HA 3423/3-1, Es 88/12-1, 88/12-1)
- Deutsche Herzstiftung (F/13/10)
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- pathological cardiac hypertrophy, engineered heart tissue, in vitro model, cardiomyocyte hypertrophy, endothelin-1, ETA receptor, endothelin B receptor, phenylephrine, fetal gene program, collagen deposition, glucose utilization, contractile force, diastolic relaxation, heart failure, cardiac remodeling
- MeSH terms
- Animals, Animals, Newborn, Cells, Cultured, Fibrosis, Glycolysis, Cardiomegaly, Models, Biological, Rats, Inbred Lew, Gene Expression, Rats, Wistar, Tissue Engineering, Myocytes, Cardiac, Rats, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. https://app.cochat.ai/papers/10.1007/s00395-012-0307-z
- The paper
- Hirt, M. N., Sörensen, N. A., Bartholdt, L. M., Boeddinghaus, J., Schaaf, S., Eder, A., Vollert, I., Stöhr, A., Schulze, T., Witten, A., Stoll, M., Hansen, A., & Eschenhagen, T. (2012). Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Research in Cardiology. https://doi.org/10.1007/s00395-012-0307-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.